Skip to main content
Premium Trial:

Request an Annual Quote

RXi, EyeGate to Collaborate on Ocular Delivery of RNAi Drugs


RXi Pharmaceuticals said this week that it has forged a collaboration with EyeGate Pharma to work on ocular delivery approaches for RNAi-based therapeutics.

The deal will evaluate EyeGate's iontophoresis technology in delivering RXi's self-delivering RNAi compounds in preclinical models, RXi said.

Each party will contribute technology, expertise, and resources to the effort, RXi said. Additional terms were not disclosed.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.